China’s 15th Five‑Year Plan was officially adopted on March 12, 2026, which defines the country’s economic and industrial priorities for the next five years. This article highlights the key implications and opportunities for foreign investors.
The revised Foreign Trade Law introduces a more structured and security focused approach to trade governance. While signaling continued openness, the law raises compliance expectations across IP, data, and supply chains for foreign businesses.
Effective May 15, 2026, China’s revised Drug Administration Law implementation rules introduce market and data exclusivity protections for certain drugs in an effort to incentivize R&D of innovative and under-researched treatments.
China’s labor market is entering a new phase of adjustment. For employers in 2026, success depends less on scale and more on precision in role design, location planning, and talent investment.
Hong Kong offers a sophisticated and reliable trademark system. For multinational businesses, understanding registration rules and jurisdictional differences is essential to managing brand risk in Greater China.
Hong Kong is repositioning itself in 2026 as a strategic APAC investment hub, supported by revived capital markets, stable macroeconomic fundamentals, and deep financial liquidity.
We hope you're enjoying this China Edition.
To receive any of our other complimentary regional editions, including ASEAN, Vietnam, India, Middle East, or our Asia weekly round-up you can add or change subscriptions. Or newly subscribe a friend.
This 2026 edition of An Introduction to Doing Business in China provides practical guidance to help investors and executives navigate China’s evolving business environment with confidence.
This 2026 edition of An Introduction to Doing Business in China provides practical guidance to help investors and executives navigate China’s evolving business environment with confidence.
Do you have any feedback? Our teams would love to hear from you!
